ESH 2021 - BeiGene Targeting the TLR pathway with BTK inhibitors in Waldenström’s Macroglobulinemia (WM)
Saturday, 16th October 2021, 14:30 – 15:30 (CEST)
Steven Treon Director Bing Center for Waldenström’s Macroglobulinemia, Senior Physician, Dana-Farber Cancer Institute; Professor of Medicine, Harvard Medical School Boston, USA